Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Hiddo Lambers Heerspink is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes: A Crossover Trial
Beernink, J., Jongs, N., Doelman, C., Laverman, G. & Heerspink, H., 24-Mar-2025, In: Jama network open. 8, 3, 11 p., e251689.Research output: Contribution to journal › Article › Academic › peer-review
1 Citation (Scopus) -
Authors' Reply: Effects of Zibotentan and Dapagliflozin on Fluid Retention in Patients with CKD: Need More Evidence
Heerspink, H. J. L. & Smeijer, J. D., Feb-2025, In: Journal of the American Society of Nephrology. 36, 2, p. 324 1 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open AccessFile8 Downloads (Pure) -
Canagliflozin and iron metabolism in the CREDENCE trial
Koshino, A., Heerspink, H. J. L., Jongs, N., Badve, S. V., Arnott, C., Neal, B., Jardine, M., Mahaffey, K. W., Pollock, C., Perkovic, V., Hansen, M. K., Bakker, S. J. L., Wada, T. & Neuen, B. L., 1-Apr-2025, In: Nephrology Dialysis Transplantation. 40, 4, p. 696-706 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Downloads (Pure) -
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials
Chatur, S., Vaduganathan, M., Fletcher, R. A., Perkovic, V., Heerspink, H., Arnott, C., Pollock, C., Mahaffey, K. W., Neal, B., Jardine, M., Solomon, S. D. & Neuen, B. L., 23-Jan-2025, (E-pub ahead of print) In: European Journal of Heart Failure.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)6 Downloads (Pure) -
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial
Siriwardana, A., Buizen, L., Jun, M., Kotwal, S., Arnott, C., Jardine, M. J., Levin, A., Heerspink, H. J. L., Charytan, D. M., Pollock, C., Perkovic, V. & Neuen, B. L., Apr-2025, In: Diabetes, Obesity and Metabolism. 27, 4, p. 1972-1979 8 p.Research output: Contribution to journal › Article › Academic › peer-review
1 Citation (Scopus)
Activities
-
The George Institute for Global Health, Sydney
Lambers Heerspink, H. (Visiting researcher)
Feb-2024Activity: Visiting an external institution › Professional
-
Supervision of PhD student Abdulfataah Mohamed
Stevens, J. (Co-supervisor), Lambers Heerspink, H. (Supervisor), Gansevoort, R. (Supervisor) & van de Merbel, N. (Co-supervisor)
9-Jan-2022 → 9-Jan-2025Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
European Association for the Study of Diabetes (EASD) Barcelona 2019
Lambers Heerspink, H. (Invited speaker)
17-Sept-2019Activity: Talk and presentation › Academic presentation › Academic
-
ASN Kidney week
Lambers Heerspink, H. (Speaker)
7-Nov-2019 → 9-Nov-2019Activity: Talk and presentation › Academic presentation › Academic
-
Basis principes in farmacokinetiek van geneesmiddelen en invloed van obesitas
Stevens, J. (Speaker) & Heerspink, H. (Speaker)
29-Jan-2019Activity: Talk and presentation › Professional or public presentation › Professional
Datasets
-
Additional file 1 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Lienczewski, C. (Contributor), Karihaloo, A. (Contributor), Kretzler, M. (Contributor), Dutius Andersson, A.-M. (Contributor), Pontrelli, P. (Contributor), Gesualdo, L. (Contributor), Sharma, K. (Contributor), Welberry Smith, M. (Contributor), Gooding, K. M. (Contributor), Shore, A. C. (Contributor), Ibberson, M. (Contributor), Lambers Heerspink, H. (Contributor), Gomez, M. F. (Contributor), Gilchrist, M. (Contributor), Nuutila, P. (Contributor), Teh, I. (Contributor), Mansfield, M. (Contributor), Papale, M. (Contributor), Banks, R. E. (Contributor), Bailey, J. (Contributor), Andress, D. (Contributor), Koivuviita, N. (Contributor), Sourbron, S. (Contributor), Tobin, K. (Contributor), Metsärinne, K. (Contributor), Zetterqvist, A. (Contributor), Garcia Hernandez, A. (Contributor), De Zeeuw, D. (Contributor), Ball, C. (Contributor), Grenier, N. (Contributor), Saunavaara, V. (Contributor), Maziarz, M. (Contributor), Gilmour, P. S. (Contributor), Shelley, D. (Contributor) & Puppala, S. (Contributor), University of Groningen, 29-Jun-2020
DOI: 10.6084/m9.figshare.12586625.v1
Dataset
-
Supplementary Material for: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in CKD
Tuttle, K. R. (Contributor), Rossing, P. (Contributor), Hauske, S. J. (Contributor), Cronin, L. (Contributor), Hussain, J. (Contributor) & Heerspink, H. J. L. (Contributor), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.24458905.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Study_Design_and_Baseline_Characteristics_for_Aldosterone_Synthase_Inhibition_in_CKD/24458905/1
Dataset
-
Supplementary Material for: Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial
Lam, D. (Contributor), Nadkarni, G. N. (Contributor), Mosoyan, G. (Contributor), Neal, B. (Contributor), Mahaffey, K. W. (Contributor), Rosenthal, N. (Contributor), Hansen, M. K. (Contributor), Lambers Heerspink, H. (Contributor), Fleming, F. (Contributor) & Coca, S. G. (Contributor), figshare Academic Research System, 11-Jan-2022
DOI: 10.6084/m9.figshare.18133754.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Clinical_Utility_of_KidneyIntelX_in_Early_Stages_of_Diabetic_Kidney_Disease_in_the_CANVAS_Trial/18133754/1
Dataset
-
Dataset for: Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease
Tighiouart, H. (Contributor), Vonesh, E. (Contributor), Lambers Heerspink, H. (Contributor), Staplin, N. (Contributor), Lewis, J. (Contributor), Inker, L. (Contributor), Ying, J. (Contributor) & Greene, T. (Contributor), University of Groningen, 31-Jul-2019
DOI: 10.6084/m9.figshare.8214638.v1
Dataset
-
Supplementary Material for: The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Jardine, M. J. (Creator), Mahaffey, K. W. (Creator), Neal, B. (Creator), Agarwal, R. (Creator), Bakris, G. L. (Creator), Brenner, B. M. (Creator), Bull, S. (Creator), Cannon, C. P. (Creator), Charytan, D. M. (Creator), De Zeeuw, D. (Creator), Edwards, R. (Creator), Greene, T. (Creator), Lambers Heerspink, H. (Contributor), Levin, A. (Creator), Pollock, C. (Creator), Wheeler, D. C. (Creator), Xie, J. (Creator), Zhang, H. (Creator), Zinman, B. (Creator), Desai, M. (Creator) & Perkovic, V. (Creator), Karger Publishers, 13-Dec-2017
DOI: 10.6084/m9.figshare.5696959, https://karger.figshare.com/articles/Supplementary_Material_for_The_Canagliflozin_and_Renal_Endpoints_in_Diabetes_with_Established_Nephropathy_Clinical_Evaluation_CREDENCE_Study_Rationale_Design_and_Baseline_Characteristics/5696959
Dataset
Press/Media
-
Hoe afslankmedicijnen het hele lichaam veranderen: ‘Mijn hoofd roept niet meer om eten’
29/03/2025
1 Media contribution
Press/Media: Expert Comment › Popular
-
智康弘义宣布SC0062临床II期糖尿病肾病队列研究达到12周主要终点 | 项目进展
25/12/2024
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Diabetesmedicijn Ozempic heeft ook positief effect bij chronische nierschade
25/10/2024 → 08/11/2024
3 items of Media coverage, 4 Media contributions
Press/Media: Expert Comment › Popular
-
Semaglutide in patinenten met nierziekte
27/10/2024
1 Media contribution
Press/Media: Expert Comment › Professional
-
BioCity will present the late-breaking clinical trial data of its ETA selective antagonist SC0062 at the American Society of Nephrology (ASN) 2024 wit
14/10/2024
1 item of Media coverage
Press/Media: Public Engagement Activities › Professional
Prizes
-
American Society of Nephrology Donald Seldin Young Investigotar LifeTime Award
Lambers Heerspink, H. (Recipient), 2024
Prize › Professional
-
-
-